Aortic Valve Insufficiency – Page 3

Novo Nordisk and Valo Health Expand AI-Driven Collaboration to Develop Novel Treatments for Obesity, Type 2 Diabetes, and Cardiovascular Disease

4 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, biotech, Cardiovascular Diseases, Computational Technique, Diabetes, Drug Development, Nordisk, Obesity, Valo Health

Novo Nordisk, Valo Health, AI, Obesity, Type 2 Diabetes, Cardiovascular Disease, Drug Development, Computational Biotech

Pfizer and PostEra Expand AI-Driven Drug Discovery Partnership to Include Antibody-Drug Conjugates (ADCs)

4 months ago talkbio0Tagged Antibody-Drug, Antibody-Drug Conjugates, Aortic Valve Insufficiency, Chemistry, Pharmaceutical, Drug Discovery, Immunostimulating conjugate (antigen), Laboratory, Pfizer, Pfizer/, PostEra, Proton Platform, Small Molecule

AI-driven drug discovery, Antibody-Drug Conjugates (ADCs), Pfizer, PostEra, AI Lab, Proton platform, small molecule therapeutics, medicinal chemistry.

FDA Introduces New Guidance on AI for Drug Approval Submissions in 2025

4 months ago talkbio0Tagged Advice, Aortic Valve Insufficiency, Artificial Intelligence, Drug Approval, Drug Development, Medical Devices, regulatory decision-making, United States Food and Drug Administration

FDA, AI, drug approval, guidance, regulatory decision-making, medical devices, artificial intelligence, drug development

Carecode Revolutionizes Brazilian Healthcare with AI-Powered Customer Service, Secures $4.3M Funding

4 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Automation, brazilian, Carecode, Customer, Health care facility, Services

Carecode, AI, Healthcare, Customer Service, Automation, Funding, Brazilian Healthcare

GSK and Relation Therapeutics Collaborate on Fibrosis and Osteoarthritis Research with AI-Driven Approach

4 months ago talkbio0Tagged Aortic Valve Insufficiency, Degenerative polyarthritis, Drug Discovery, Fibrosis, Machine Learning, Relative (related person), SmithKline Beecham

Relation Therapeutics, GSK, Fibrosis, Osteoarthritis, AI in drug discovery, Machine learning in biotech

Dimension Secures $500M for Second Fund, Focusing on the Intersection of Science and Technology

5 months ago talkbio0Tagged Aortic Valve Insufficiency, biotech, Capital, Dimensions, innovation, Machine Learning, Science, Technology, venture

Dimension, Venture Capital, Science, Technology, Biotech, AI, Machine Learning, Life Sciences, Innovation

Cleerly Secures $192M for Heart Attack-Predicting AI Technology

5 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Cleerly, Coronary Artery Scanning, Heart Disease

Cleerly, AI, Heart Disease, Coronary Artery Scanning, Funding

Healthcare Evolution 2025: AI, IRA, and GLP-1s Redefine the Industry

5 months ago talkbio0Tagged advancements, Aortic Valve Insufficiency, Biopharma, DNA Integration, Glucagon-Like Peptide 1, Health care facility, Healthcare technology, Impact food supplement, Ira (eukaryote), Pharmaceutical Industry Shifts, Telemedicine, trends qualifier, Value-Based Care

AI in Healthcare, IRA Impact on Biopharma, GLP-1 Medications, Healthcare Trends 2025, Value-Based Care, Telemedicine Integration, Pharmaceutical Industry Shifts, Healthcare Technology Advancements